Cancer and mortality among users and nonusers of snus

International Journal of Cancer

Volumn 123, Issue 1, 2008, Pages 168-173

  Roosaar, Ann ^a   Johansson, Anna L V ^a   Sandborgh Englund, Gunilla ^a   Axéll, Tony ^b   Nyrén, Olof ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b HALMSTAD HOSPITAL   (Sweden)

Author keywords

Cancer; Epidemiology; Mortality; Smokeless tobacco

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER MORTALITY; CANCER RISK; CAUSE OF DEATH; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; DEMOGRAPHY; EXPOSURE; FOLLOW UP; HAZARD RATIO; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MOUTH CANCER; NEOPLASM; OUTCOME ASSESSMENT; PHARYNX CANCER; POPULATION RESEARCH; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; QUANTITATIVE ANALYSIS; REGISTER; SMOKELESS TOBACCO; STATISTICAL SIGNIFICANCE;

ADOLESCENT; ADULT; AGED; ALCOHOL DRINKING; COHORT STUDIES; CONFIDENCE INTERVALS; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; MEDICAL RECORD LINKAGE; MIDDLE AGED; MOUTH NEOPLASMS; NEOPLASMS; ODDS RATIO; PHARYNGEAL NEOPLASMS; PROPORTIONAL HAZARDS MODELS; REGISTRIES; RISK ASSESSMENT; RISK FACTORS; SCANDINAVIA; SMOKING; TOBACCO USE DISORDER; TOBACCO, SMOKELESS;

EID: 43949125846     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.23469     Document Type: Article

References (45)

1. Cogliano V, Straif K, Baan R, Grosse Y, Secretan B, El Ghissassi F. Smokeless tobacco and tobacco-related nitrosamines. Lancet Oncol 2004;5:708.
2. Foulds J, Kozlowski L. Snus - what should the public-health response be? Lancet 2007;369:1976-8.
3. Gartner CE, Hall WD, Vos T, Bertram MY, Wallace AL, Lim SS. Assessment of Swedish snus for tobacco harm reduction: an epidemiological modelling study. Lancet 2007;369:2010-14.
4. Rodu B, Jansson C. Smokeless tobacco and oral cancer: a review of the risks and determinants. Crit Rev Oral Biol Med 2004;15:252-63.
5. Lewin F, Norell SE, Johansson H, Gustavsson P, Wennerberg J, Biorklund A, Rutqvist LE. Smoking tobacco, oral snuff, and alcohol in the etiology of squamous cell carcinoma of the head and neck: a population-based case-referent study in Sweden. Cancer 1998;82:1367-75.
6. Schildt EB, Eriksson M, Hardell L, Magnuson A. Oral snuff, smoking habits and alcohol consumption in relation to oral cancer in a Swedish case-control study. Int J Cancer 1998;77:341-6.
7. Rosenquist K, Wennerberg J, Schildt EB, Bladstrom A, Hansson BG, Andersson G. Use of Swedish moist snuff, smoking and alcohol consumption in the aetiology of oral and oropharyngeal squamous cell carcinoma. A population-based case-control study in southern Sweden. Acta Otolaryngol 2005;125:991-8.
8. Boffetta P, Aagnes B, Weiderpass E, Andersen A. Smokeless tobacco use and risk of cancer of the pancreas and other organs. Int J Cancer 2005;114:992-5.
9. Luo J, Ye W, Zendehdel K, Adami J, Adami HO, Boffetta P, Nyren O. Oral use of Swedish moist snuff (snus) and risk for cancer of the mouth, lung, and pancreas in male construction workers: a retrospective cohort study. Lancet 2007;369:2015-20.
10. Bolinder G, Alfredsson L, Englund A, de Faire U. Smokeless tobacco use and increased cardiovascular mortality among Swedish construction workers. Am J Public Health 1994;84:399-404.
11. Axell T. A prevalence study of oral mucosal lesions in an adult Swedish population. Odontol Revy 1976;27:1-103.
12. Mattsson B, Wallgren A. Completeness of the Swedish Cancer Register. Non-notified cancer cases recorded on death certificates in 1978. Acta Radiol Oncol 1984;23:305-13.
13. Mattsson B, Rutqvist LE, Wallgren A. Undernotification of diagnosed cancer cases to the Stockholm Cancer Registry. Int J Epidemiol 1985;14:64-9.
14. Johansson LA, Westerling R. Comparing Swedish hospital discharge records with death certificates: implications for mortality statistics. Int J Epidemiol 2000;29:495-502.
15. Total Population Register: Statistics Sweden [Internet] 2005 [cited 2007 June 7]. Available from: www.scb.se.
16. Levitz JS, Bradley TP, Golden AL. Overview of smoking and all cancers. Med Clin North Am 2004;88:1655-75, xiii.
17. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Tobacco smoke and involuntary smoking. IARC Monogr Eval Carcinog Risks Hum 2004;83:1-1438.
18. Grambsch PM, Therneau TM. Proportional hazards tests and diagnostics based on weighted residuals,10.1093/biomet/81.3.515. Biometrika 1994;81:515-26.
19. StataCorp. Stata Statistical Software: Release 9, College Station, TX: StataCorp LP [Internet] 2005 [cited 2007 May 5]. Available from: www.stata.com.
20. Blomqvist G, Hirsch JM, Alberius P Association between development of lower lip cancer and tobacco habits. J Oral Maxillofac Surg 1991;49:1044-7; Discussion 8-9.
21. Gilljam H, Galanti MR. Role of snus (oral moist snuff) in smoking cessation and smoking reduction in Sweden. Addiction 2003;98:1183-9.
22. WHO. Smokeless tobacco control. Report of a WHO Study Group. World Health Organ Tech Rep Ser 1988;773:1-81.
23. Osterdahl BG, Jansson C, Paccou A. Decreased levels of tobacco-specific N-nitrosamines in moist snuff on the Swedish market. J Agri Food Chem 2004;52:5085-8.
24. Hecht SS, Carmella SG, Murphy SE, Riley WT, Le C, Luo X, Mooney M, Hatsukami DK. Similar exposure to a tobacco-specific carcinogen in smokeless tobacco users and cigarette smokers. Cancer Epidemiol Biomarkers Prev 2007;16:1567-72.
25. Stepanov I, Jensen J, Hatsukami D, Hecht SS. Tobacco-specific nitrosamines in new tobacco products. Nicotine. Tobacco Res 2006;8:309-13.
26. Squires WG, Jr, Brandon TA, Zinkgraf S, Bonds D, Hartung GH, Murray T, Jackson AS, Miller RR. Hemodynamic effects of oral smokeless tobacco in dogs and young adults. Prev Med 1984;13:195-206.
27. Herman EH, Vick JA, Strong JM, Parker RJ, Geyer HM, III, Kramer ED, Higgins KM, Sistare FD. Cardiovascular effects of buccal exposure to dermal nicotine patches in the dog: a comparative evaluation. J Toxicol Clin Toxicol 2001;39:135-42.
28. Huckabee KD, Barnes RT, Williams AG, Jr, Fan WL, Downey HF. Effects of snuff on regional blood flow to the cheek and tongue of anesthetized dogs. Oral Surg Oral Med Oral Pathol 1993;76:729-35.
29. Fant RV, Henningfield JE, Nelson RA, Pickworth WB. Pharmacokinetics and pharmacodynamics of moist snuff in humans. Tobacco Control 1999;8:387-92.
30. Benowitz NL, Porchet H, Sheiner L, Jacob P, III. Nicotine absorption and cardiovascular effects with smokeless tobacco use: comparison with cigarettes and nicotine gum. Clin Pharmacol Ther 1988;44:23-8.
31. Wolk R, Shamsuzzaman AS, Svatikova A, Huyber CM, Huck C, Narkiewicz K, Somers VK. Hemodynamic and autonomic effects of smokeless tobacco in healthy young men. J Am Coll Cardiol 2005;45:910-14.
32. Bolinder G, Noren A, Wahren J, De Faire U. Long-term use of smokeless tobacco and physical performance in middle-aged men. Eur J Clin Invest 1997;27:427-33.
33. Hirsch JM, Hedner J, Wernstedt L, Lundberg J, Hedner T. Hemodynamic effects of the use of oral snuff. Clin Pharmacol Ther 1992;52:394-401.
34. Johansson SE, Sundquist K, Qvist J, Sundquist J. Smokeless tobacco and coronary heart disease: a 12-year follow-up study. Eur J Cardiovasc Prev Rehabil 2005;12:387-92.
35. Huhtasaari F, Lundberg V, Eliasson M, Janlert U, Asplund K. Smokeless tobacco as a possible risk factor for myocardial infarction: a population-based study in middle-aged men. J Am Coll Cardiol 1999;34:1784-90.
36. Hergens MP, Ahlbom A, Andersson T, Pershagen G. Swedish moist snuff and myocardial infarction among men. Epidemiology 2005;16:12-16.
37. Mehta MC, Jain AC, Mehta A, Billie M. Cardiac arrhythmias following intravenous nicotine: experimental study in dogs. J Cardiovasc Pharmacol Ther 1997;2:291-8.
38. Villarreal FJ, Hong D, Omens J. Nicotine-modified postinfarction left ventricular remodeling. Am J Physiol 1999;276:H1103-H1106.
39. Sridharan MR, Flowers NC, Hand RC, Hand JW, Horan LG. Effect of various regimens of chronic and acute nicotine exposure on myocardial infarct size in the dog. Am J Cardiol 1985;55:1407-11.
40. Henley SJ, Thun MJ, Connell C, Calle EE. Two large prospective studies of mortality among men who use snuff or chewing tobacco (United States). Cancer Causes Control 2005;16:347-58.
41. Roosaar A, Johansson AL, Sandborgh-Englund G, Nyren O, Axell T. A long-term follow-up study on the natural course of snus-induced lesions among Swedish snus users. Int J Cancer 2006;119:392-7.
42. Roosaar A, Yin L, Johansson AL, Sandborgh-Englund G, Nyren O, Axell T. A long-term follow-up study on the natural course of oral leukoplakia in a Swedish population-based sample. J Oral Pathol Med 2007;36:78-82.
43. Roosaar A, Yin L, Sandborgh-Englund G, Nyren O, Axell T. On the natural course of oral lichen lesions in a Swedish population-based sample. J Oral Pathol Med 2006;35:257-61.
44. Rodu B, Stegmayr B, Nasic S, Cole P, Asplund K. Evolving patterns of tobacco use in northern Sweden. J Intern Med 2003;253:660-5.
45. Furberg H, Lichtenstein P, Pedersen NL, Bulik C, Sullivan PF. Cigarettes and oral snuff use in Sweden: prevalence and transitions. Addiction. 2006;101:1509-15.